Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bracco Imaging Deutschland, formerly known as Bracco-Byk, is a leading provider of diagnostic imaging solutions in the German market. Established in 1989 as a joint venture between the Italian Bracco Group and the German company Byk Gulden, it became a wholly-owned subsidiary of Bracco in 2002. The company specializes in the development and distribution of contrast agents and medical devices for X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound. Its extensive portfolio includes well-known products such as Iomeron, ProHance, and SonoVue, which are essential for high-precision medical diagnostics. Headquartered in Konstanz, the company provides comprehensive support and training to healthcare professionals in the fields of radiology and cardiology. Bracco Imaging Deutschland remains a key player in the European imaging market, leveraging the global research and development capabilities of the Bracco Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bracco-Byk.